Enter Note Done
Decrease font size Increase font size

Next-generation sequencing of uveal melanoma for detection of genetic alterations predicting metastasis

View Session View Presentation
Add to Schedule Print Abstract

Posterboard#: B0230

Abstract Number: 752 - B0230

AuthorBlock: Armin R. Afshar1,2, Bertil E. Damato1,3, Jay M. Stewart1, Ritu Roy4,2, Adam Olshen4,2, Boris Bastian5,2
1Ophthalmology, University of California, San Francisco, San Francisco, California, United States; 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, United States; 3Oxford Eye Hospital and the Nuffield Department of Clinical Neurosciences, University of Oxford, , United Kingdom; 4Epidemiology & Biostastics, University of California, San Francisco, San Francisco, California, United States; 5Dermatopathology, University of California, San Francisco, San Francisco, California, United States;

DisclosureBlock: Armin R. Afshar, None; Bertil E. Damato, None; Jay M. Stewart, Genentech Code C (Consultant), Merck Code C (Consultant), Achaogen Code C (Consultant), Ritu Roy, None; Adam Olshen, None; Boris Bastian, None;

Purpose
To clinically utilize a pan-cancer, targeted next-generation sequencing assay in uveal melanoma, and to correlate results with gene expression profiling and predictive factors for metastasis.

Methods
Cohort study. Tumor samples of adult UM patients were analyzed with the UCSF500 60 and GEP. Main outcomes were copy number changes in chromosomes 1, 3, 6 and 8 and mutations in GNAQ, GNA11, SF3B1, EIF1AX, BAP1, SRSF2, U2AF1 and PLCB4. Chromosome 3 loss (a metastasis predictor) was tested for correlation with GEP class, tumor characteristics (largest basal diameter, thickness, ciliary body involvement, extraocular extension) and histology (presence of epithelioid cells, closed loops, mitotic count).

Results
The 62 patients had a mean age of 58.6 years (range, 24 – 88). Chromosome 3 loss was detected in 30 and was associated with larger basal tumor diameter (Wilcoxon test, p=0.015), higher thickness (Wilcoxon test, p=0.016) and TNM stage (Fisher test, p=0.006), epithelioid cytology (Fisher test, p=4*10-6), BAP1 mutation (Fisher test, p=8*10-12) and chromosome 8q gain (Fisher test, p=10*10-9). Class 2 tumors were much more likely to have chromosome 3 loss compared to Class 1 (odds ratio, 121; p=6*10-10). Eleven patients developed metastatic UM, of which five died during the study. All metastatic cases had chromosome 3 loss, 8 gain, BAP1 mutation and Class 2 GEP. Five Class 1 tumors had chromosome 3 loss.

Conclusions
A targeted, next-generation sequencing assay detected chromosomal copy number changes and missense mutations that correlate strongly with metastasis predictors in uveal melanoma, including gene expression profiling results.

Layman Abstract (optional): Provide a 50-200 word description of your work that non-scientists can understand. Describe the big picture and the implications of your findings, not the study itself and the associated details.